financetom
Business
financetom
/
Business
/
Deutsche Bank Loses Court Battle Related to Postbank Acquisition
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Deutsche Bank Loses Court Battle Related to Postbank Acquisition
Oct 23, 2024 7:18 AM

09:53 AM EDT, 10/23/2024 (MT Newswires) -- Deutsche Bank ( DB ) has to make increased payments to a group of former Postbank shareholders in connection with its acquisition of Postbank, according to a statement from the Cologne Higher Regional Court on Wednesday.

The court ruled in favor of the 13 plaintiffs, who said they were entitled to a payment of 57.25 euros ($61.69) per Postbank share instead of the 25 euros per share paid in 2010.

The plaintiffs were demanding payment of the difference between the amounts, according to the court's statement.

In a statement Wednesday, Deutsche Bank ( DB ) said it had booked provisions covering the plaintiffs' outstanding claims.

"The court has not allowed a further appeal to the German Federal Court," the bank said. "Deutsche Bank ( DB ) will assess whether to file a non-admission complaint (motion for leave to appeal) after receiving the written reasoning for the decision."

Price: 17.34, Change: -0.23, Percent Change: -1.30

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bausch Health Says Bausch + Lomb Subsidiary Sale Under Consideration
Bausch Health Says Bausch + Lomb Subsidiary Sale Under Consideration
Dec 12, 2024
07:50 AM EST, 12/12/2024 (MT Newswires) -- Bausch Health ( BHC ) said Thursday that it has authorized its Bausch + Lomb ( BLCO ) subsidiary to explore a potential sale, among the options under consideration to complete a previously announced plan to separate the two companies. The company believes that completing the full separation of its subsidiary, Bausch +...
Lonza seeks deals as it exits health and ingredients to focus on contract development
Lonza seeks deals as it exits health and ingredients to focus on contract development
Dec 12, 2024
* Lonza shares rise 6.7% after CHI exit announcement * Company to focus on CDMO business restructuring * Plans M&A for tech and capacity opportunities (Writes through, adding detail on CDMO business and M&A, analyst comment and share price reaction) By Isabel Demetz Dec 12 (Reuters) - Swiss contract drugmaker Lonza plans to simplify its structure and exit its capsules...
Almaden Updated on Arbitration Process with Mexico
Almaden Updated on Arbitration Process with Mexico
Dec 12, 2024
07:48 AM EST, 12/12/2024 (MT Newswires) -- Almaden Minerals Ltd. ( AAUAF ) , trading near 52 week lows, on Thursday provided an update on its international arbitration proceedings under the Comprehensive and Progressive Agreement for Trans-Pacific Partnership with the United Mexican States. While Almaden in a statement said it is vigorously pursuing this claim, its preference is for a...
Top Premarket Decliners
Top Premarket Decliners
Dec 12, 2024
07:51 AM EST, 12/12/2024 (MT Newswires) -- Keros Therapeutics ( KROS ) shares were down 72% pre-bell Thursday after the company said it voluntarily halted two treatment arms in a phase 2 study of cibotercept in combination with background therapy in patients with pulmonary arterial hypertension. Samfine Creation ( SFHG ) stock was 36% lower, extending Wednesday's fall. Intellinetics (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved